SC 13D/A - METLIFE INC (0001099219) (Subject)

SC 13D/A - METLIFE INC (0001099219) (Subject)

SC 13D/A - METLIFE INC (0001099219) (Subject)

SC 13D/A - METLIFE INC (0001099219) (Subject)

SC 13G/A - METLIFE INC (0001099219) (Subject)

SC 13G/A - METLIFE INC (0001099219) (Subject)

SC 13G/A - METLIFE INC (0001099219) (Subject)

SC 13D/A - METLIFE INC (0001099219) (Subject)

SC 13D/A - METLIFE INC (0001099219) (Subject)

SC 13D/A - METLIFE INC (0001099219) (Subject)

Citigroup analyst Michael Ward maintains MetLife (NYSE:MET) with a Buy and raises the price target from $83 to $89.

Throughout the last three months, 9 analysts have evaluated MetLife (NYSE:MET), offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 6 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 3 0 0 0 2M Ago 1 0 0 0 0 3M Ago 0 3 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $84.0, a high estimate of $86.00, and a low estimate of $80.00. Observing a 0.13% increase, the current average has risen from

Jefferies analyst Suneet Kamath maintains MetLife (NYSE:MET) with a Buy and raises the price target from $83 to $86.

Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $82 to $83.

Keefe, Bruyette & Woods analyst Ryan Krueger maintains MetLife (NYSE:MET) with a Outperform and lowers the price target from $86 to $85.

MetLife's (NYSE:MET) short percent of float has risen 4.76% since its last report. The company recently reported that it has 9.16 million shares sold short, which is 1.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.4 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest is impor

JP Morgan analyst Jimmy Bhullar maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $81 to $86.

Ratings for MetLife (NYSE:MET) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 7 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 3 0 0 0 3M Ago 0 4 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $84.0, a high estimate of $87.00, and a low estimate of $80.00. Witnessing a positive shift, the current av

Jefferies analyst Suneet Kamath maintains MetLife (NYSE:MET) with a Buy and lowers the price target from $88 to $83.

Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such

MetLife's John Wilson takes over for Kramden founder, who headed the board for two decades As a part of MetLife's, Inc. (NYSE:MET) global strategy to increase diversity in Science, Technology, Engineering and Math (STEM), the company today announced that John Wilson was named chair of the Board of Kramden Institute, a North Carolina non-profit that provides technology and training to bridge the digital divide. Wilson takes over the chair position from the organization's founder, Mark Dibner, who has overseen Kramden's growth for the last 20 years. "We are blessed to have a board of directors passionate about technology and social impact," said Cyndy Yu-Robinson, Kramden Executive Direct

Sofía Belmar to take new role with Latin America regional team and be succeeded by Mario Valdes, who currently oversees six operations in Central and Eastern Europe These changes reinforce MetLife's commitment to cross-region talent development and succession planning After six years of successfully leading MetLife's operation in Mexico – the company's third-largest global operation – Sofía Belmar-Berumen will be taking a new regional role as Head of Business Development and Transformation, Latin America. Belmar's leadership and business acumen have been critical for MetLife Mexico to become the leading player in the local insurance industry. A prominent thought leader, she is the first

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (“MetLife”), announced today that James Reid has been named CEO of Versant Health, a managed vision care company and wholly owned subsidiary of MetLife. The appointment is effective April 1. “James brings extensive and varied experience in the Group Benefits market to Versant Health,” said Todd Katz, chairman of the Versant Health Board of Directors and executive vice president, Group Benefits at MetLife. “His dedication to delivering for customers, focus on building talent and background in both sales and general management makes him ideally suited to lead Versant to new levels of growth.” Reid brings more than 30 years of experience in

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a first quarter 2021 common stock dividend of $0.46 per share. The dividend will be payable on March 15, 2021, to shareholders of record as of Feb. 5, 2021. About MetLife MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United

MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.39232690 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE:MET). Quarterly dividend of $296.875 per share on the company's 4.75% non-cu

The Human Animal Bond Research Institute (HABRI) and MetLife Pet Insurance Solutions LLC ("MetLife Pet"), one of the world's leading financial services companies, today announced a collaboration to advance their shared goal of strengthening the human-animal bond through research, education and advocacy. "At MetLife Pet Insurance, we are focused on ensuring all pet parents' have access to veterinary resources so they can confidently care for their pets and that our four-legged family members receive the care they need," said Brian Jorgensen, CEO of MetLife Pet Insurance. "We are committed to protecting and supporting the relationship between people and their pets, which is in complete align

MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, MetLife, Inc., and head of MetLife Investment Management, has provided a third quarter 2024 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030606174/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help indivi

MetLife, Inc. (NYSE:MET) today announced its third quarter 2024 results. Third Quarter Results Summary Net income of $1.3 billion, or $1.81 per share, compared to net income of $422 million, or $0.56 per share, in the third quarter of 2023. Adjusted earnings of $1.4 billion, or $1.95 per share, compared to adjusted earnings of $1.5 billion, or $1.97 per share, in the third quarter of 2023. Book value of $39.02 per share, up 33 percent from $29.34 per share at September 30, 2023. Book value, excluding accumulated other comprehensive income (AOCI) other than foreign currency translation adjustments (FCTA), of $54.72 per share, up 3 percent from $53.00 per share at September 30, 2023.

Program has supported over 80 organizations in 2024 in MetLife communities around the world MetLife Foundation today announced additional recipients of its Community Impact Grant Program (CIGP), which supports local, grassroots non-profit organizations providing immediate assistance to communities impacted by the growing income and wealth divide. The new recipients span the U.S. and Asia-Pacific region, following the program's international expansion earlier this year and announcement of a second round of 2024 funding in the U.S. CIGP was first launched in 2023 to deepen the Foundation's impact and involvement in communities where MetLife has a presence, by focusing on these areas and hav

Annual study shows that globally-mobile employees face unique challenges that require a strategic approach to providing the right resources and support Employers are increasingly optimistic about the future of globally-mobile work, with 68% of employers saying they expect it to increase, up from 45% in 2023. The demographic of those taking global assignments has also shifted with an increase in younger employees taking these roles and doing so solo. MetLife's research shows 42% of employees on global assignments do so alone vs. the 33% with their partner and spouse. This shift in the make up in globally-mobile workforce is something for employers to take note of and proactively support thi

MetLife, Inc. (NYSE:MET) today announced that its board of directors has declared a fourth quarter 2024 common stock dividend of $0.545 per share. The dividend will be payable on Dec. 16, 2024, to shareholders of record as of Nov. 5, 2024. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and t

MetLife, Inc. (NYSE:MET) today announced that for another year it has received several recognitions from Seramount for its culture of trust and inclusion, hiring practices, talent development programs, and commitment to advancing workforce diversity. "An inclusive culture where unique attributes, perspectives, voices and contributions are valued and respected is critical for the well-being of our employees and business performance," said MetLife Global Chief Diversity, Equity and Inclusion Officer Dr. Cindy Pace. "We are proud to be recognized by Seramount as we work every day to create an environment in which everyone feels like they can belong and thrive at MetLife." Seramount is a stra

As LIMRA reports a 14% increase in pension risk transfer (PRT) deals for the first half of 2024 compared to 20231, MetLife's 2024 Pension Risk Transfer Poll finds the percentage of companies with de-risking goals who plan to completely divest their defined benefit (DB) pension plan liabilities has increased to 93%, up from 89% in the 2023 Poll. About half, 52%, plan to divest two to five years from now, with an average of 3.8 years. "As the Poll and other market data indicates, the pension risk transfer market continues its bullish growth and will likely continue to remain strong in the near future," says Elizabeth Walsh, vice president, U.S. Pensions, MetLife. "As a market leader focused

AM Best has affirmed the Long-Term Issue Credit Rating (Long-Term IR) of "a-" (Excellent) on the $750 million, 5.3% senior unsecured notes, due December 2034, of MetLife, Inc. (MetLife) (headquartered in New York, NY) (NYSE:MET). The outlook of this Credit Rating (rating) is stable. The rating applies to the recently issued $250 million, 5.3% senior unsecured notes, due 2034, and its existing $500 million, 5.3% senior unsecured notes, due 2034, issued June 5, 2024. The additional notes offered constitute a further issuance of, and are fungible with, the existing notes. The $250 million of additional notes were priced at 104.611% of principal amount, plus accrued interest from June 5, 2024,

4 - METLIFE INC (0001099219) (Issuer)